SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

Achilles Therapeutics Q1 EPS $(8.38)

Achilles Therapeutics (NASDAQ:ACHL) reported quarterly losses of $(8.38) per share.

05/11/2021 07:25
Achilles Therapeutics (NASDAQ:ACHL) reported quarterly losses of $(8.38) per share.